Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Outbreak of CRO and Big Pharma Activity in China

publication date: Oct 22, 2008

Over the past week, China biopharma has witnessed a remarkable series of milestones, as major players have opened new facilities or announced plans to expand. Most of the activity has been centered in Shanghai, especially in the biopharma-rich Zhangjiang Park. Three Shanghai-based CROs held their Grand Opening ceremonies for new labs, while two international big pharmas inaugurated new offices or announced plans for expansion. More details..

Stock Symbols: (NYSE: LLY) (NYSE: SNY) (NYSE: CRL) (AIM: HCM)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here